Vision Improvement for Legally Blind Dry AMD Patients
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age50-100
SponsorOptimal Acuity Corporation
About this trial
This retrospective observational study is intended to assess the feasibility of using a nonsignificant risk device for vision improvement for legally blind dry AMD patients.
Eligibility criteria
Qualifiers
Male or Female
Any race
Patient is at least 50 years old.
Patient must have dry AMD in the study eye.
Disqualifiers
Visually significant cataract in the study eye
Presence of a visually significant posterior capsule opacity if prior cataract surgery has been performed in the study eye
Any visually significant disease process in any ocular structure other than AMD that would affect vision in the study eye
Previous corneal surgery in the study eye
Trial design
Treatments tested in this trial
- Clear-K Low Vision Aid Treatment
Treatment groups
40 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov